Axsome Therapeutics, Inc. (AXSM)
NASDAQ·Healthcare·Biotechnology
$183.37
-2.15%
Mkt Cap $9.54B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 23, 2026 | $193.36M | $194.69M | +0.69% | -$0.70 | -$0.71 | -1.43% | — | — |
| Q4 2025 Nov 3, 2025 | $191.33M | $170.99M | -10.63% | -$0.82 | -$0.94 | -14.63% | — | — |
| Q3 2025 Aug 4, 2025 | $140.02M | $150.04M | +7.16% | -$1.00 | -$0.92 | +8.00% | — | — |
| Q2 2025 May 5, 2025 | $140.44M | $121.46M | -13.51% | -$1.26 | -$0.80 | +36.51% | — | — |
| Q1 2025 Feb 18, 2025 | $119.51M | $118.77M | -0.62% | -$1.00 | -$0.96 | +4.00% | — | — |
| Q4 2024 Nov 12, 2024 | $98.37M | $104.76M | +6.50% | -$1.38 | -$1.34 | +2.90% | — | — |
| Q3 2024 Aug 5, 2024 | $86.92M | $87.17M | +0.28% | -$1.30 | -$1.24 | +4.62% | — | — |
| Q2 2024 May 6, 2024 | $86.66M | $75.00M | -13.46% | -$1.20 | -$1.09 | +9.17% | — | — |
| Q1 2024 Feb 20, 2024 | $67.56M | $71.53M | +5.88% | -$1.21 | -$0.73 | +39.67% | — | — |
| Q4 2023 Nov 6, 2023 | $55.75M | $57.79M | +3.67% | -$1.24 | -$1.32 | -6.45% | — | — |
| Q3 2023 Aug 7, 2023 | $40.93M | $46.70M | +14.10% | -$1.24 | -$1.00 | +19.35% | — | — |
| Q2 2023 May 8, 2023 | $26.62M | $94.58M | +255.28% | -$1.13 | -$0.22 | +80.53% | — | — |
| Q1 2023 Feb 27, 2023 | $21.75M | $24.37M | +12.03% | -$1.18 | -$1.28 | -8.47% | — | — |
| Q4 2022 Nov 7, 2022 | $16.64M | $16.85M | +1.26% | -$1.10 | -$1.03 | +6.36% | — | — |
| Q3 2022 Aug 9, 2022 | $6.92M | $8.82M | +27.49% | -$1.19 | -$1.06 | +10.92% | — | — |
| Q2 2022 May 2, 2022 | — | — | — | -$1.02 | -$1.03 | -0.98% | — | — |
| Q1 2022 Mar 1, 2022 | — | — | — | -$0.99 | -$0.90 | +9.09% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.94 | -$0.93 | +1.06% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.88 | -$0.86 | +2.27% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.83 | -$0.78 | +6.02% | — | — |